Ingrezza Sprinkle Capsules Received FDA Approval for Tardive Dyskinesia in Adults
The new formulation was approved to help patients with tardive dyskinesia who have trouble swallowing.
Eiryw Roberts Mitchell Mathis Neurocrine Biosciences Division Of Psychiatry Products Drug Administration Ingrezza Sprinkle
Source: psychiatrictimes.com